RNA splicing factors regulated by HPV16 during cervical tumour progression.
about
HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cellsCytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytesControl of human papillomavirus gene expression by alternative splicingMultiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressorsAlternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation.IGF expression in HPV-related and HPV-unrelated human cancer cells.Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-κ transcription in keratinocytes.CCCTC-binding factor recruitment to the early region of the human papillomavirus 18 genome regulates viral oncogene expression.Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).RNA Binding Proteins that Control Human Papillomavirus Gene Expression.IGF1 mRNA isoform expression in the cervix of HPV-positive women with pre-cancerous and cancer lesionsHuman papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapiesHuman Papillomavirus E2 Protein: Linking Replication, Transcription, and RNA Processing.Human papillomavirus gene expression is controlled by host cell splicing factors.NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.Three-dimensional cell culture models for investigating human viruses.Regulation of p14ARF expression by HPV-18 E6 variants.Telomerase Induction in HPV Infection and Oncogenesis.Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation.Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation.
P2860
Q21559659-1DFA3B9C-24A2-4EBA-AED1-F21D3D5A8D5AQ24627249-A6797239-918B-4870-A031-B189368E3F5FQ28073341-8FD71410-F85B-4857-9884-F9170133291CQ33592653-107E53F2-E652-4A9A-9AC9-51CE4108DF3AQ33748580-C5C9EB88-A34B-423D-891D-D09258C57D05Q33800261-83CEC0B4-4D4B-4363-BBFC-F16BAED55BACQ33859710-1FF56378-3A05-4C75-BA62-E8678D949467Q34000598-63242420-137C-40A0-A114-3D4D9A670096Q34447216-1D591D43-BA48-46B8-B49D-216BB0580B22Q34593811-4C558CEB-07B4-4A39-9307-1B2F47ADD62BQ34988558-7FC2FE71-27D4-4DAB-B6C3-2D8D8FC87952Q35116264-E70BBCBB-6CE8-412E-BB37-526B82BA4887Q35488871-CDC3B734-1BAA-492C-8D52-9C6D8C966ADDQ35641431-BCB5317A-7641-40FE-AFBA-FEF6672B6537Q35834013-153CF745-25E3-490C-9691-6E91A2248AA4Q36230453-E5A44BAC-2689-4A08-B11F-98C7DFFD643BQ36481634-3500E446-09CC-4BAE-AAE7-9CB3BBBCFC18Q37252986-DD92CA1C-23BA-4A5F-8939-58508B25DFA6Q38027954-50D112F4-B61E-4B8A-8B2F-ADDA1D4712B1Q38865962-C0AFB55C-ECCA-46FE-A40E-4C9C4508BCF6Q39002340-749E0C33-C165-41D0-9CDC-FFEB4739C652Q39114874-67783C6E-169B-422D-A158-5B07E452D238Q39429557-507B1992-503C-475B-8A3A-A916DCD75BCDQ39932759-DE145C21-5A00-474B-9679-422FFC6EE943Q40059698-8BB1210B-9AA8-4289-814F-BB65B4A09616Q55613070-55D3F767-2B58-4A58-B844-3F43268903E3
P2860
RNA splicing factors regulated by HPV16 during cervical tumour progression.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
RNA splicing factors regulated by HPV16 during cervical tumour progression.
@en
RNA splicing factors regulated by HPV16 during cervical tumour progression.
@nl
type
label
RNA splicing factors regulated by HPV16 during cervical tumour progression.
@en
RNA splicing factors regulated by HPV16 during cervical tumour progression.
@nl
prefLabel
RNA splicing factors regulated by HPV16 during cervical tumour progression.
@en
RNA splicing factors regulated by HPV16 during cervical tumour progression.
@nl
P2093
P2860
P356
P1476
RNA splicing factors regulated by HPV16 during cervical tumour progression
@en
P2093
David Millan
Melanie McFarlane
Sarah Mole
Steven G Milligan
Thanaporn Chuen-Im
P2860
P304
P356
10.1002/PATH.2608
P50
P577
2009-11-01T00:00:00Z